CITADEL ADVISORS
THIS Cryptocurrency ETF could soar up to 5,400%, claim some Wall Street analysts. Here's what you should know
According to experts at Wall Street, cash-rich billionaires are on a buying spree of a certain Cryptocurrency ETF, that may soar to unimaginable level in a matter of time.
Rahul Gandhi: Has the prince found his golden fleece in Karnataka?
Rahul goes on his Bharat Jodo Yatra, slays his political opponents with his speeches, runs into a variety of people, tries to learn from them, and his journey leads him to victory in Karnataka elections. Compare it with the archetypal story from ancient myths that has become a universal template of human condition, finding its way now into film plots — to claim his throne, the prince must step out of his princedom; set out on a perilous journey through enchanted forests, magical mountains, accursed springs and illusionary grottos of goblins, witches and mighty dragons, all to bring back a precious magical object that will grant him the right to his throne.
Hedge fund Elliott exited Twitter during Q2 amid takeover frenzy, filing shows
The filing on Monday, showed that Elliott no longer owned any common stock in Twitter on June 30. It had owned 10 million shares at the end of the first quarter.
PAG, partners buy controlling stake in Optimus for Rs 2,000 crore
PAG, a leading alternative investment firm focused on Asia-Pacific, along with consortium partners CX Partners and Samara Capital, on Wednesday said they have reached an agreement to acquire a controlling stake in Hyderabad-based pharmaceutical firm Optimus Drugs.
Carlyle, Viyash Life Sciences to launch pharma investment platform
CA Hull Investments, an affiliated entity of Carlyle Asia Partners and Viyash, and the platform will primarily focus on investment in Active Pharmaceuticals Ingredients. Although Carlyle did not announce financial terms, sources said this would be a $300 mln platform.
Oyo eyes $12-15B IPO valuation; Unacademy gets a breather
Oyo is aiming for a valuation of $12-15 billion for its upcoming IPO, in which some investors will sell parts of their holdings. These won’t include Oyo’s founder Ritesh Agarwal, however, who is likely to hold on to his entire stake.
- Go To Page 1
Ant may dilute Paytm stake
Less than a month ago we reported that Jack Ma's Ant Group may not be able to participate in Paytm's IPO. Now, sources tell us the Chinese company will probably reduce its 30.33% stake in Paytm's parent firm ahead of its IPO.
Hedge fund manager Gabriel Plotkin's GameStop short, dissected
On Thursday, he spent more than five hours answering U.S. lawmakers' questions about how his firm Melvin Capital Management, which shed 53% of its value in January, lost so much money and whether it wasn't playing by the rules.
Former Morgan Stanley India head’s SPAC to tap diaspora in US
KludeIn 1 Acquisition Corp., a special purpose acquisition company, raised about $173 million in an initial public offering in January.
Analysis: To the brink and back on GameStop - Wall Street vs Reddit
The experience of this manager and a handful of others interviewed by Reuters over the last days, who all requested anonymity for fear of personal threats from retail investors, is a keyhole into a week of losses on Wall Street they say was far worse for them than last year's historic pandemic sparked sell-off.
Citadel alums start year's biggest hedge fund at $2 billion
More than half of US hedge fund startups in 2019 have been long-short equity managers and this year’s equity rally has made the strategy the best-performing among hedge fund managers.
All the nightmares for stock investors start in the bond market
There are a lot of people waiting for the world to end because of this bond market.
Hedge fund titans who bet big on India now say they were scammed
Not only did the bet fizzle out, some global hedge funds even say they fell victim to a massive fraud.
Taj Mahal named second-best UNESCO world heritage site after Angkor Wat
The survey lists the UNESCO Cultural and Natural heritage sites best rated by travellers around the globe.
Healthy dose: Sequoia Capital pumps in Rs 100 crore in La Renon Healthcare
La Renon expects to close the current financial year with topline of around Rs 325 crore with a target of reaching Rs 1,000 crore in the next 4-5 years.
India Agribusiness Fund invests Rs 75 crore in Beloorbayir Biotech
Beloorbayir is the largest manufacturer of glucosamine in India which is often used as a supplement to ease the joint pain caused by arthritis.
Goldman Sachs plans to challenge Blackstone on hedge fund start-ups
Goldman Sachs is seeking money to bankroll fledgling hedge funds, its second attempt to break into a biz now dominated by Blackstone Group.
Load More
